Treatment of infections caused by carbapenemase-producing Enterobacterales

01-oct-2022 | Revista: Revista Española de Quimioterapia

M Íñigo, J L Del Pozo 1

Abstract

Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of carbapenem-resistant Enterobacterales has been reported.

The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection.

New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits.

CITA DEL ARTÍCULO Rev Esp Quimioter. 2022 Oct;35 Suppl 3:46-50. doi: 10.37201/req/s03.11.2022. Epub 2022 Oct 24.

ver publicación en pubmed

Nuestros autores

Imagen de la Dra. Melania Iñigo. Microbióloga. Clínica Universidad de Navarra

Dra. Melania Iñigo Pestaña Ver Curriculum

Especialista Servicio de Microbiología Clínica

Sede Madrid

Imagen Dr. José Luis del Pozo León, Departamento Microbiología

Dr. José Luis del Pozo León Ver Curriculum

Director Servicio de Enfermedades Infecciosas

Sede Pamplona